Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The new AI software predicts melanoma outcomes more accurately than traditional methods.

Removing the outer skin layer increases drug absorption and offers non-invasive treatment options, with some methods allowing for quick skin recovery.

Lasers can trigger skin reactions, especially in darker skin, and more research is needed to improve treatments.

Acanthosis Nigricans is the most common skin sign of insulin resistance.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Cell-based therapies offer better repigmentation for larger vitiligo areas, with CD8+ T cell count as a potential biomarker for success.

The 532 nm laser effectively reduces facial vascular and pigmented lesions, with the VISIA system reliably assessing treatment results.

Skin changes were less common, and photo assessments were unreliable.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Advanced human skin models improve drug development and could replace animal testing.

Methylprednisolone treatment helps most alopecia areata patients, but young age, extensive hair loss, and low vitamin D can affect results.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Intralesional triamcinolone effectively reduces pain and inflammation in hidradenitis suppurativa flares.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

A 3D skin model helps study wound healing better than traditional methods.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Cemiplimab can cause alopecia areata, but it can be treated successfully.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Certain skin symptoms can indicate underlying body-wide illnesses.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

The dermal regeneration template is effective in skin regeneration, reducing scarring, and has potential for future improvements.

A new non-invasive method can analyze skin mRNA to understand skin diseases better.

Intralesional triamcinolone is more effective than the Excimer laser for treating localized alopecia areata.